Search Results

No more blind spots, only decisions rooted in reality. You’ll know how to use  kinetics to sharpen decisions: Confirm whether your system has truly equilibrated Make decisions with confidence. 🟢 40 years of expertise at your fingertips: Explore the complete library

We're launching with 10 on-demand lessons , each featuring:   A short, focused video A concise written Explore Terry's Corner Better decisions start with better pharmacology.

feature breaks down exactly how to think about inhibitors with rigor and speed, so you can make better decisions It’s built for scientists and teams who want fewer tabs and faster decisions—one scroll that blends structure GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

today and get direct access to decades of pharmacology experience that turn complex systems into better decisions Here’s what you’ll get: Weekly expert sessions  that turn messy data into clear decisions On-demand access Make decisions with confidence. 🟢 40 years of expertise at your fingertips: Explore the complete library

And here’s the danger: if you can’t tell how  a drug is working, every downstream decision—SAR, lead You’ll know how to use them to sharpen discovery decisions. pharmacologists refining fundamentals, scientists challenging legacy assumptions, and leaders who need decision-ready

Terry Kenakin to elevate your science and sharpen your decisions. Sharpen your discovery decisions ➤ Dr. GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

Misinterpreted mechanisms delay decision-making and weaken downstream results. This is the kind of insight that makes the difference between a dead-end program and a well-informed decision

Practical insight into how enzyme activation and inhibition shape drug safety, efficacy, and design decisions partners rather than static filters, drug discovery scientists can make faster, smarter optimization decisions Decades of kinetic insight  reframed into actionable tools for faster, cleaner decision-making.

Hodson made what seemed like a purely tactical decision: choose a research elective to focus on exams Early decisions don’t need to be perfect. They need to keep you moving. Curiosity compounds.

September 2022 "The transparency of the cornea along with its dense sensory innervation and resident The cornea is the most densely innervated tissue of the body and possesses both immune and vascular privilege

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need translational strategy, classified updates, and curated jobs—trusted by scientists, teams, and biotech decision-makers

clarity in GPCR drug discovery Even the strongest GPCR programs stall—not from bad data, but from buried decisions

For GPCR imaging, their strengths are practical and decisive: Consistency from batch to batch Long-term Imaging Possible Behind every technical advance in this story sits something less tangible but equally decisive

docking, and machine learning can transform GPCR research from descriptive science into predictive decision-making For industry leaders, this is an operational opportunity: integrate prediction into decision-making.  

chose to write a review on genetic variation in susceptibility to alcoholism and opioid addiction—a decision Catherine's decision to defer pharmacy school was a leap of faith that opened new doors.

Denied stronger medication in the midst of the opioid crisis, he turned to the one place that still offered

delivers every week: practical tools and critical intelligence to elevate your science and sharpen your decisions GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

. ✅ Decision speed to prioritize smarter leads  and avoid avoidable attrition. Decades of kinetic insight  reframed into actionable tools for faster, cleaner decision-making.

These aren’t abstract academic puzzles—they’re decision points that can make or break a program. What emerges is not just more data—it’s the right data, positioned to inform strategic decision-making

design, weekly lesson help you apply key concepts like binding, signaling, and kinetics in practical, decision-shaping

Neuropeptides exhibit distinct characteristics which includes their post-translational processing, release from dense

Teams equipped with deep GPCR pharmacology insights make different decisions. Kenakin revealed  the decision workflow for ranking agonists with translational intent.

receptor conformation affect signaling outcomes, a whole-cell environment can strengthen early-stage decision-making formats  Why image-based confirmation (and transparent Ki reporting) can strengthen medicinal chemistry decisions

Ambiguous Decision Gates: Molecules advance or stall based on vibes, not criteria.

It was one of the best decisions I’ve made.

technical rigor as foundation Technology boom — scaling curiosity Strategic shift — experiments as decisions

Curiosity wasn’t just something Michelle felt — it started steering every decision she made.

GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

Terry’s Corner is built for scientists who want to move faster , think sharper , and make smarter decisions

to shape future topics Built for discovery-phase teams, pharmacologists refining their methods, and decision-makers